Bioactivity:

Mizagliflozin is a sodium-glucose transporter inhibitor( Ki of 27 nM for human SGLT1).�Mizagliflozin displays 303-fold selectivity over SGLT2.�Mizagliflozin is used as an antidiabetic drug that can modify postprandial blood glucose excursion.�Mizagliflozi

CAS nr:

666843-10-3

Purity:

98%

Molecular Weight:

564,67

SMILES:

O=C(N)C(C)(C)CNCCCOC1=CC=C(CC2=C(C(C)C)NN=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)C(C)=C1

Formula:

C28H44N4O8

Pathway:

GPCR/G Protein

Target:

SGLT